IP Library Granted Patent US 9,540,625
Granted Patent B2
US 9,540,625 · App. 14/382,462 · Granted Jan 10, 2017

Human carbonic anhydrase II with increased physical stability

Inventors: Uno Carlsson (Söderköping, SE); Martin Karlsson (Linköping, SE)
Assignee: Inzymes Biotech AB
C12N9/88B01D53/84C12Y402/01001B01D2255/804B01D2257/504Y02C10/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,540,625
App. No.
14/382,462
Granted
Jan 10, 2017
Kind
B2
Abstract

An isolated polypeptide having carbonic anhydrase activity, the sequence of which corresponds to modified human carbonic anhydrase II is described. The isolated polypeptide comprises the mutations A23C, S99C, L202C, C205S and V241C and the polypeptide has increased physical stability compared to wild type carbonic anhydrase II. Further, the polypeptide comprises disulfide bridges between C23 and C202 and/or between C99 and C241.

Claims (11)

1. An isolated polypeptide having carbonic anhydrase activity, the sequence of which corresponds to modified human carbonic anhydrase II, wherein the polypeptide comprises the mutations A23C, S99C, L202C, C205S and V241C relative to wild type human carbonic anhydrase II having the amino acid sequence of SEQ ID NO:9, has increased physical stability compared to wild type carbonic anhydrase II and further comprises disulfide bridges between C23 and C202 and/or between C99 and C241; and

wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 8.

2. The isolated polypeptide having carbonic anhydrase activity according to claim 1 , having a thermodynamic stability increased by 23.5 kJ/mol compared to wild type carbonic anhydrase II.

3. The isolated polypeptide having carbonic anhydrase activity according to claim 1 , having a melting point increased by 18.5° C. compared to wild type carbonic anhydrase II.

4. The isolated polypeptide having carbonic anhydrase activity according to claim 1 , having an activation energy of unfolding increased by 25 kJ/mol compared to wild type carbonic anhydrase II.

5. The isolated polypeptide having carbonic anhydrase activity according to claim 1 , having a rate of unfolding in water at 21° C. that is about 22.000 times slower compared to wild type human carbonic anhydrase II.

6. The isolated polypeptide having carbonic anhydrase activity according to claim 1 , having a half-life of 86 days at 60° C., 8 days at 65° C. and 1.6 days at 70° C.

7. The isolated polypeptide having carbonic anhydrase activity according to claim 1 , wherein the isolated polypeptide maintains its increased physical stability compared to wild type carbonic anhydrase II in aqueous solutions of ethanol amines, comprising methyldiethanolamine (MDEA), monoethanolamine (MEA), diethanolamine (DEA), and aminoethoxyethanol.

8. A method of using an isolated polypeptide having carbonic anhydrase activity according to claim 1 for extraction of carbon dioxide from a carbon dioxide containing medium.

9. The method according to claim 8 , wherein the isolated polypeptide having carbonic anhydrase activity is used in a bioreactor.

10. A method of preparing an isolated polypeptide of SEQ ID NO: 8, according to claim 1 comprising acceleration of the formation of disulfide bridges by incubation of the polypeptide at elevated temperatures of 25-60° C. in the presence of an oxidizing agent at a pH of 7-10.

Assignments (2)
CHANGE OF NAME Recorded Sep 26, 2014
From: RATIONAL ENZYME MINING REM AB
To: INZYMES BIOTECH AB
Reel/Frame 033832/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2014
From: CARLSSON, UNO; KARLSSON, MARTIN
To: RATIONAL ENZYME MINING REM AB
Reel/Frame 033652/0175 →
Priority Claims (1)
SE 1250400 · Apr 23, 2012 · national
Continuity (1)
Related Publication 20150191711A1 · Jul 9, 2015